White Paper

Enabling CDMOs To Focus On Core Priorities

Outsourcing Business Human Resources--GettyImages-1305829382

Several factors contribute to the recent CDMO market segment growth in biopharmaceuticals. To remain competitive, CDMOs must control costs and focus on their core mission of drug development and manufacturing, often achieved by outsourcing pre-production activities to industry experts. This results in greater efficiencies and lower operational costs. Partnering with cGMP chemical suppliers can simplify the drug production process, as they provide pre-weighed and dispensed dry powders and pre-made process liquids/buffers. Companies like Thermo Fisher Scientific offer end-to-end solutions for CDMOs, leading to significant cost savings and improved operational efficiencies. A detailed analysis of the CDMO's pre-manufacturing process can identify bottlenecks and propose solutions, resulting in a more efficient workflow. Providers of complete chemical workflow solutions can further enhance their value by offering comprehensive supply chain support.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online